Interestingly, our demonstration that TP5 not only prevents cancer-associated thymic regression but actively promotes regeneration in chemotherapy-induced immunosuppression models suggests a fundamental mechanism addressing the immunological imbalance underlying cancer progression. This evidence concerns the gene TMPO and cancer.